Allergy and immunology practices are facing growing prior authorization pressure in 2026. Payers are closely reviewing biologics, immunotherapy, diagnostics, and long-term treatment plans. What used to be routine approvals now require detailed documentation and constant follow-up. With added regulatory changes in the 2026 CMS Physician Fee Schedule, payer scrutiny has intensified, making prior authorization delays a common barrier to timely care. Adopting smarter tactics can help practices maintain access, reduce denials, and protect revenue.
Authorization for ongoing treatment with allergy and immunology therapy often requires multiple prescription medications that can be very expensive. Therefore, payers are closely evaluating the utilization of allergy and immunology PA services and the clinical justification for the services rendered. This blog will list some ways your practice can navigate this challenge easily.
Submitting Proper Authorization Requests as Early as Possible
Denials can occur because the practice only identifies that the patient is not eligible for an authorization after the initial evaluation has been completed. The most practical solution for this is to determine the patient’s authorization eligibility at the time of the patient’s initial appraisal.
The longer the practice waits to submit an authorization request prior to when the medications or treatment are scheduled to be provided, the higher the likelihood of denial due to time constraints.
Payers require documentation of medical necessity in a clear form, especially for the use of biological/long-term therapy. Clear and concise documentation will help providers to process the requests for prior authorizations more quickly and reduce the need for follow-up requests. These steps also support more accurate allergy and immunology billing, preventing discrepancies between billed services and authorized services.
Preparing for Peer-to-Peer Reviews
The increase in peer-to-peer reviews for biological and what will soon be known as immunotherapies. To enhance the likelihood of a successful outcome:
- Develop clearly defined clinical summaries
- Reference any payer-specific guidelines
- Ensure that responsible providers are available and able to address concerns
- Document all outcomes at the time of the conversation
Preparation will shorten the timeline of the review.
Audit Readiness for 2026
Approval does not remove the risk of being audited. There is an increase in post-service reviews of specialty services. Audit readiness involves:
- Secure storage of authorization approvals
- Comparison of what services were provided with what was approved
- Detailed documentation of any claims made
- Performing regular internal compliance audits
When a practice is prepared, it will protect its reimbursement.
The Benefits of Outsourcing Prior Authorization
As more authorizations are written and as more authorizations become complicated, internal teams may not be able to perform the volume of work required. Many allergy and immunology practices opt to outsource prior authorization services in order to keep up with their efficiency:
- Knowledge of the different payers
- More timely follow-ups and escalations
- The ability to track and report consistently
- Lower administrative burden
When the outsourcing process is consistent with the internal workflow of the practice, it can provide for better care. As the number of requirements increases and the scrutiny from payers becomes even more significant, providers will have to approach any kind of authorization proactively. It may be very beneficial for practices to consider outsourcing their allergy and immunology prior authorization to RCM Workshop to improve the efficiency of the approval process so that they can continue to focus on providing the best care they can provide for patients.
